Table 2.
Baseline patient characteristics and Geriatric Assessment measures
| Patient Characteristics (n=51 patients) | ||
|---|---|---|
| Age (years) | Median 72 yo | Range 65–86 |
| Cancer Type | n = pts | % |
| Ovarian | 47 | 92 |
| Peritoneal | 2 | 4 |
| Fallopian Tube | 2 | 4 |
| Cancer stage | ||
| I | 4 | 8 |
| II | 1 | 2 |
| III | 19 | 37 |
| IV | 27 | 53 |
| Treatment | ||
| Single-agent chemotherapy | 14 | 27 |
| Platinum-doublet chemotherapy | 34 | 67 |
| Chemotherapy plus Bevacizumab | 3 | 6 |
| Line of chemotherapy | ||
| 1st line | 23 | 45 |
| 2 or more lines | 28 | 55 |
| Standard dose | ||
| No | 18 | 35 |
| Yes | 33 | 65 |
| Comorbidities | ||
| Arthritis | 24 | 47 |
| Circulation problems | 7 | 14 |
| Depression | 11 | 22 |
| Diabetes | 4 | 8 |
| Emphysema | 2 | 4 |
| Glaucoma | 4 | 8 |
| High blood pressure | 19 | 37 |
| Heart Disease | 7 | 14 |
| Liver/Kidney Disease | 1 | 2 |
| Other cancers | 14 | 27 |
| Osteoporosis | 20 | 39 |
| Stomach disorders | 12 | 24 |
| Stroke | 1 | 2 |
| Geriatric Assessment Measures | Mean ± SD | Range |
| Functional status | ||
| Physician-rated KPS | 80±10 | 60–100 |
| Self-rated KPS | 87±10 | 60–100 |
| IADL OARS scale 0–14 | 13±1 | 8–14 |
| MOS physical 0–100 | 75±22 | 20–100 |
| No. of falls in past 6 months | 0±1 | 0–6 |
| Timed get up and go test (sec) | 11±5 | 5.2–36.7 |
| Cognitive status (BOMC) scale 0–28 | 4±5 | 0–28 |
| Nutritional status | ||
| % unintentional weight loss in 6 mo. | 5±7 | 0–23 |
| Psychological status | ||
| HADS scale 0–42 | 8±5 | 0–24 |
| Social Support: MOS scale | 86±17 | 45.8–100 |
| Social Activity: MOS scale | 57±18 | 0–87.5 |
| Comorbidity | ||
| No. of comorbidities | 2±2 | 0–5 |
| No. of prescription medications | 4±3 | 0–17 |
Depression Scale; IADL= Instrumental Activities of Daily Living; KPS=Karnofsky Performance Scale; OARS IADL= Older Americans Resources and Services Instrumental Activities of Daily Living.